Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ferran

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Transplantation Proceedings|March 20, 1999
Adenovirus-mediated gene transfer of the anti-apoptotic protein A20 in rodent islets inhibits IL-1 beta-induced NO releaseS T Grey, M B Arvelo, W M Hasenkamp, et al.
Transplantation Proceedings|February 1, 1996
Xenotransplantation: a possible solution to the shortage of donor organsF H Bach, H Winkler, C J Wrighton, et al.
Virology|August 26, 2020
The VSV matrix protein inhibits NF-κB and the interferon response independently in mouse L929 cellsKaitlin A Marquis, Rachel L Becker, Amanda N Weiss, et al.
Presse Medicale (Paris, France : 1983)|November 27, 1991
[Acute clinical syndrome associated with OKT3 administration. Prevention by single injection of an anti-human TNF monoclonal antibody]B Charpentier, C Hiesse, C Ferran, et al.
The Journal of Biological Chemistry|July 26, 1996
A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanismJ T Cooper, D M Stroka, C Brostjan, et al.
Transplantation Proceedings|February 1, 1997
A20 expression inhibits endothelial cell activationJ T Cooper, D M Stroka, C Brostjan, et al.
Clinical Transplantation|February 1, 1996
Genetic engineering of endothelial cells to ameliorate xenograft rejectionF H Bach, S C Robson, C J Wrighton, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Constitutive NF-κB Activation is Amplified by VSV in Aggressive PC3 Prostate Cancer Cells that Resist Viral OncolysisAlaa A Abdelmageed, Jack Smerczynski, Lute Douglas, et al.
Sangre|January 1, 1979
[Granulocyte transfusion. Its efficacy as a complementary treatment of infections in the granulocytopenic patient (author's transl)]M P Vivancos Pujol, A Alemany, M Clavo, et al.
Transplantation|February 15, 1997
Human monocytes activate porcine endothelial cells, resulting in increased E-selectin, interleukin-8, monocyte chemotactic protein-1, and plasminogen activator inhibitor-type-1 expressionM T Millan, C Geczy, K M Stuhlmeier, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Transplantation Proceedings|March 20, 1999
Adenovirus-mediated gene transfer of the anti-apoptotic protein A20 in rodent islets inhibits IL-1 beta-induced NO releaseS T Grey, M B Arvelo, W M Hasenkamp, et al.
Transplantation Proceedings|February 1, 1996
Xenotransplantation: a possible solution to the shortage of donor organsF H Bach, H Winkler, C J Wrighton, et al.
Virology|August 26, 2020
The VSV matrix protein inhibits NF-κB and the interferon response independently in mouse L929 cellsKaitlin A Marquis, Rachel L Becker, Amanda N Weiss, et al.
Presse Medicale (Paris, France : 1983)|November 27, 1991
[Acute clinical syndrome associated with OKT3 administration. Prevention by single injection of an anti-human TNF monoclonal antibody]B Charpentier, C Hiesse, C Ferran, et al.
The Journal of Biological Chemistry|July 26, 1996
A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanismJ T Cooper, D M Stroka, C Brostjan, et al.
Transplantation Proceedings|February 1, 1997
A20 expression inhibits endothelial cell activationJ T Cooper, D M Stroka, C Brostjan, et al.
Clinical Transplantation|February 1, 1996
Genetic engineering of endothelial cells to ameliorate xenograft rejectionF H Bach, S C Robson, C J Wrighton, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Constitutive NF-κB Activation is Amplified by VSV in Aggressive PC3 Prostate Cancer Cells that Resist Viral OncolysisAlaa A Abdelmageed, Jack Smerczynski, Lute Douglas, et al.
Sangre|January 1, 1979
[Granulocyte transfusion. Its efficacy as a complementary treatment of infections in the granulocytopenic patient (author's transl)]M P Vivancos Pujol, A Alemany, M Clavo, et al.
Transplantation|February 15, 1997
Human monocytes activate porcine endothelial cells, resulting in increased E-selectin, interleukin-8, monocyte chemotactic protein-1, and plasminogen activator inhibitor-type-1 expressionM T Millan, C Geczy, K M Stuhlmeier, et al.
Pageof 10